WIZDOM VOLUME ONE / SELF PACED
The pharmacology of cannabinoids, taught by someone who publicly retracts what he got wrong.
Eight modules, forty video clips, around five and a half hours. Quizzes, a sixty question final examination, and a certificate of completion. Built for licensed practitioners and for the health coaches who work alongside them.
One payment, lifetime access. EUR 297 until 31 October 2026, EUR 697 from 1 November.
THE PROBLEM
A patient asks you about cannabis, and you go looking for an answer the way you would for any other molecule.
Not a vague question. A specific one. Whether the CBD oil they bought interacts with the anticoagulant they have been on for two years. Why the edible did nothing for three hours and then did far too much. Whether the thing they read about a terpene being thirty times stronger than aspirin is true.
And you find something strange. Nearly every source has a shop attached. The webinar is hosted by a producer. The infographic is from a dispensary. The confident number in the article traces back to a mouse study from 1998 that nobody quoting it has read.
So you do the responsible thing and say you do not know. Which is correct, and also unsatisfying, because the patient is going to use it anyway, and now they will get their information from a forum.
The gap is not your fault. Cannabinoid pharmacology was not in the curriculum, and the market that grew up around it had no commercial reason to teach it honestly. Terpene wheels are prettier than dose response curves. Entourage effect sells better than the evidence for this in humans is thin.
This course closes that gap with pharmacology instead of enthusiasm. The molecules, the receptors, the curves, the routes and the interactions. And module by module, where the evidence is strong, where it is weak, and where the industry favourites fall apart under a normal amount of scrutiny.
FIT
Who this is for, and who it is not for
This is for you if
You are a pharmacist, physician, nurse, nurse practitioner or allied health professional whose patients use cannabis whether or not you were consulted
You are a health coach or wellness practitioner who wants to talk about this accurately and stay clearly inside your scope
You are fluent in pharmacology generally and want the cannabinoid specific layer: receptors, curves, routes, CYP interactions
You can tolerate being told that something you currently believe is not well supported
You would rather have five sentences you can defend than fifty you cannot
This is not for you if
You want to be told cannabis treats a condition. This course makes no therapeutic claims and names no condition as treatable
You are looking for a prescribing protocol or a dosing chart to apply to patients. There is not one here, and anyone selling you one is selling you a guess
You need an accredited qualification for a licensing body. The certificate here is a certificate of completion and nothing more
You are a patient looking for help with your own use. This is pitched at practitioners and assumes clinical vocabulary throughout
You want your existing beliefs about the plant confirmed
WHY THIS ONE SOUNDS DIFFERENT
For years I taught a fixed twenty-eight day tolerance reset from stage.
It was a good line. Clean, memorable, practitioners wrote it down, and audiences liked having a number. Twenty-eight days off and your receptors are back where they started.
Then I went looking for the study that said twenty-eight days. What I found instead was a literature that does not support a fixed number at all. Receptor recovery is not a stopwatch. It varies by person, by exposure, by region of the brain, and the tidy figure I had been handing out was a simplification that had quietly become a fact through repetition. Mine included.
So inside this course I say it plainly. I taught a fixed twenty-eight day rule from stage for years, it was wrong, and I have stopped teaching it. I am telling you that before you buy rather than after, because it is the only credential that actually matters here. Anyone can list letters after their name. The question to ask about a cannabis educator is simpler. What have they publicly taken back?
That habit runs through the whole course. In Module 2 I put five of the industry's most repeated terpene claims on trial, including ones I used to repeat myself, and most do not survive. I teach the terpene wheel properly and then dismantle it. I show the THC ceiling across 26,102 samples rather than asserting a number. I perform what is honestly an autopsy on the entourage effect. In one lesson I spend my own screen time hunting for the study that would destroy my own patent, out loud, on camera, because if that study exists you deserve to see it more than I deserve to keep the patent.
I declare my conflicts of interest in Module 1, before teaching anything. I live with Crohn's disease, which I disclose openly because it shapes why I do this work and you should be able to weigh that. None of this is humility as a marketing posture. It is the only defensible way to teach a subject where the commercial pressure to overstate is this strong.
THE CURRICULUM
Eight modules. Forty video clips. Around five and a half hours.
Watch in order the first time, then use it as a reference for the rest of your career.
__________
MODULE 1
Foundations and the honest frame
Before any pharmacology, a method. What cannabis is, framed for a clinical audience. Chemovars rather than strains, and why the strain name on the jar is an expired ID. Then marker against mechanism, and the five evidence tags used throughout the course, so every claim you meet afterwards arrives pre-labelled with how much weight it can carry. You also hear my declared conflicts of interest at the start rather than buried in a footer.
__________
MODULE 2
The plant's chemistry
The longest module, and the one that does the most damage to what you currently believe. Decarboxylation and why the raw plant is not the drug. The cannabinoid roster and what each is actually known to do rather than what it is marketed as doing. How CBD dials THC down, and why a one to one product is not THC with a safety net but a pharmacologically different drug. Then the teardown: the terpene wheel taught exactly as the industry teaches it and then taken apart, five common claims put on trial, what actually survives the trip from plant to patient, the THC ceiling measured across 26,102 samples, and a full autopsy of the entourage effect, rebuilt at the end as something you can defend.
__________
MODULE 3
The endocannabinoid system
The system that was here long before the plant was. Anandamide and 2-AG, what they do and how briefly they last. CB1 and CB2, where they sit, what they modulate, and why that geography explains so much of what you see clinically. Then beyond the CB receptors, the wider network that makes the tidy two receptor story incomplete. This is the module that turns cannabis from a mysterious exception into ordinary, tractable physiology.
__________
MODULE 4
Pharmacodynamics, how it acts
The central idea of the whole course: a dose is a position on a curve, not a number on a label. The biphasic curve and why more can do less. Why that curve exists, and the honest limits of any sentence beginning cannabis does. Tolerance, and what a break actually resets, taught with the evidence rather than with my old twenty-eight day rule. And the five ways a molecule can behave at a receptor, so that agonist, partial agonist and allosteric modulator stop being vocabulary and start being predictions.
__________
MODULE 5
Pharmacokinetics and ADME
Why there is no such thing as the curve, only the curve for this route in this person. Routes and bioavailability. Absorption and the two peaks. Inhalation against oral, and what the difference in onset and duration does to everything downstream. Which route is forgiving, which is not, and the redosing trap that catches patients on the oral route again and again for reasons that are entirely predictable once you can see the pharmacokinetics. Then distribution, metabolism and excretion, including why detectable is not the same as impaired.
__________
MODULE 6
Drug interactions and safety
The module with the highest immediate clinical value, and the one most often left out. The liver and the CYP enzymes, opened with a worked transplant case. Why grapefruit is the clue that makes the whole thing intuitive. The asymmetry that surprises most practitioners: CBD is the inhibitor here, while THC inhibits nothing of consequence. Then the specific pairs ranked by strength of evidence rather than by how alarming they sound: clobazam, valproate, warfarin, CNS depressants, tacrolimus, and the smoking and CYP1A2 relationship that has nothing to do with cannabinoids at all.
__________
MODULE 7
From pharmacology to the person
Where the pharmacology meets the room. Start low and go slow traced back to the evidence it actually rests on, which is not where most people assume. Then reading a certificate of analysis and a label: two patients with one jar and the story of the 22 percent number, and the trace terpene barcode with the statistics that refuse to protect it.
__________
MODULE 8
Integration and assessment
The five sentences still standing after the teardown. Short, defensible, and specific enough to repeat to a colleague or a prescriber without qualifying every word. Most courses end by expanding what you believe. This one ends by narrowing it to what you can defend. Then the final examination: mostly clinical scenarios, 75 percent to pass.
__________
BONUS
Outside the spine
Three pieces that did not belong in the teaching order but were too useful to cut. What tobacco does to medical cannabis in a shared joint. The time I went hunting for the study that would destroy my own patent. And how to be honest and useful on Monday morning with a patient whose beliefs you have just demolished.
WHAT YOU GET
What is included
Forty pre-recorded video clips, roughly five and a half hours of teaching, streamed on demand
A quiz after every module, so you find out you missed something while it is still cheap to fix
A final examination drawn at random from a sixty question pool, 75 percent to pass, three attempts
A certificate of completion on passing, issued in your name and downloadable as a PDF
Lifetime access. No subscription, no renewal, no expiry on your login
Free updates to Volume One. When a module is corrected or re-recorded you get the new version at no cost, and given the subject and given my track record, assume there will be corrections
Watch on any device, at your own pace, in any order after the first pass
PRICE
EUR 297. One payment. Lifetime access.
That price holds until 31 October 2026. From 1 November it is EUR 697.
That is not a countdown gimmick. The course is finished, and the launch window is how I am pricing the first cohort of self serve students, the ones who get it before there is a single review to read. On 1 November the price changes and stays there. If you are reading this in November and it still says 297, I have failed to keep my own word, and you should tell me.
The honest version of the value argument, since you have heard the dishonest one before. Built and delivered as a live cohort programme with contact hours, this material prices around EUR 997. That is the comparable, and it is a real number rather than a crossed out decoration. You are not paying it for a straightforward reason: the recording is already made, adding one more student costs me almost nothing, and charging you as though it cost me a cohort would be dishonest. What you lose at 297 is the live contact and the cohort. What you keep is all eight modules, the examination and the certificate.
There are no limited seats, because a video has no seats, and nothing on this page counts down by the second. There is one date, 31 October, and it is real.
WHO IS TEACHING
Gil Luxenbourg
A medical cannabis educator who teaches practitioners rather than patients. The work is pharmacology first: receptors, curves, routes and interactions, with every claim carrying an explicit evidence tag so students always know how much weight it holds.
He is not a physician and not a prescriber, and says so throughout the course. Treatment decisions belong with the prescriber, without exception.
He is best known among colleagues for retracting his own teaching in public. The fixed twenty-eight day tolerance reset he taught from stage for years is now taught as an example of how a memorable number becomes a fact through repetition. He lives with Crohn's disease and discloses this openly, along with his commercial interests, in Module 1 before teaching anything.
QUESTIONS
Before you decide
No. WIZDOM Volume One is not accredited by any professional body, and completing it does not earn CE, CME or CPD credit unless your own regulator independently chooses to recognise self directed learning, which is entirely their call. What you receive is a certificate of completion. It is evidence that you finished the course and passed the examination. It is not a licence, not a diploma and not a qualification to practise anything.
You need to be comfortable with basic pharmacology vocabulary: receptors, agonists, half life, first pass metabolism, CYP enzymes. The course is built for licensed practitioners and for health coaches who work alongside them, and it does not stop to define those terms from scratch. If terms like partial agonist are new to you, this will be steep.
About five and a half hours of video across forty clips, plus the module quizzes. Most people take between one and three weeks at a few clips per sitting. There is no schedule and no deadline, and nothing expires.
Yes. It draws questions at random from a sixty question pool, the pass mark is 75 percent, and it is mostly clinical scenarios. It is a real examination with a real fail state. If it were not possible to fail it, the certificate would be worth nothing and so would your time.
You have three attempts in total. Because questions are drawn at random from a larger pool, a retake is not the same paper again. Between attempts you keep full access to every module, so the sensible move is to go back to the material the questions exposed rather than straight into the next attempt. If you use all three without passing, you keep lifetime access to the content, you simply do not receive the certificate.
No. Cannabis law differs by country, state and profession, and it changes. What you are permitted to say, recommend, supply or document is governed by your own jurisdiction and your own regulator, and you need to check both. This course teaches pharmacology, not compliance.
No. It teaches the pharmacology underneath the conversation. It does not tell you to start, stop or change any patient's treatment, it provides no dosing protocols to apply, and it makes no claim that cannabis treats, cures or helps any condition. What it gives you is the ability to understand what is happening, ask sharper questions, spot an interaction worth escalating, and explain a curve to a colleague without overstating what is known.
No, and if that is what you are hoping for you will be disappointed by roughly module two. Several modules are spent showing where popular claims are weaker than they are presented, including claims I used to make myself. The most positive thing this course does is label the evidence accurately, in both directions.
If the course is not what this page said it was, tell me within 30 days and I will refund you in full. You do not need to justify it and I will not ask you to sit through a call.
No. Testimonials describing medical outcomes are not something this course will ever publish, because they would function as therapeutic claims regardless of the disclaimer attached. Judge the course on the curriculum and on the free module instead.
PLEASE READ BEFORE ENROLLING
Important
This is education, not medical advice. Nothing in this course constitutes medical advice, a diagnosis, a treatment recommendation, or a clinical directive for any individual patient.
The instructor is not a doctor and not a prescriber. Gil Luxenbourg is a medical cannabis educator. He does not prescribe and does not hold a prescriber's authority in any jurisdiction. He says so repeatedly on tape throughout the course.
No therapeutic claims are made. This course does not claim that cannabis or any cannabinoid treats, cures, prevents or helps any medical condition. Where it discusses evidence, it labels the strength of that evidence explicitly, including where that evidence is weak, contested or absent.
Treatment decisions belong with the prescriber. Nothing here should be used to start, stop, adjust or substitute any patient's treatment.
The certificate is a certificate of completion only. It is not an accredited qualification, not a licence, not a diploma, and it does not authorise you to practise, prescribe, dispense or advise beyond the scope your own credentials and regulator already permit.
Practise within your scope and your law. Cannabis law and professional scope vary by jurisdiction and change over time. You are responsible for confirming what you may lawfully do in your own location.
Conflicts of interest are declared. The instructor's commercial interests are disclosed in Module 1, before any teaching begins.
Not ready to buy? Watch Module 1 first.
Module 1 is the foundations module: the five evidence tags, and my declared conflicts of interest. It is the part of the course that tells you how to judge the rest of it, including how to judge me. Watch it, then decide.
One payment, lifetime access, thirty day refund. EUR 697 from 1 November 2026.